Looking for analysis of halogenated organic compounds such as chlorinated solvents in your pharma products? With our brand new Electron Capture Detector (ECD) we’ve got just the right equipment to help!

The team at QUINTA-ANALYTICA are very pleased to announce delivery of our latest innovative piece of technology in the form of specialized selective gas chromatography detectors, allowing us to offer even greater selectivity and sensitivity to our clients and partners.

By increasing our ability to detect compounds in matrices further, our new micro-electron capture detector provides trace-level analysis of halogenated organic compounds and aromatic pollutants, and is the most sensitive ECD on the market.

Produced by Agilent Technologies, and boasting reliability combined with unprecedented sensitivity and accurate quantitation of samples containing compounds with unknown concentrations, it is able to offer detection in the ranges from femtograms to nanograms per microliter.

By bolstering our line-up in this key area, Quinta are confident in repeating the last twenty years of history by remaining a fully certified top-class services provider to the global pharmaceutical industry.

Get in touch to learn more!

Additional News

  • 18 July 2023

    Challenges of a large-scale study of breast cancer

    Our bioanalytical experts and a high-profile client team up for the development of a new therapy for breast cancer.

  • 29 June 2023

    EU funding for Quinta-Analytica laboratory in Brno (CZ) was succesfully completed.

    After two years, the project to finance new equipment for the Quinta-Analytica laboratory in Brno was successfully completed. The investment from European Regional Development Fund was used in this project.

  • 22 June 2023

    Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies

    EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency